Skip to main content

Table 1 Baseline characteristics of study participants (N = 2383)

From: Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

 N (%)
Sociodemographics
 Age (years): mean (SD)33·1 (9·3)
 Female gender1372 (57·6)
Education
 None, primary or some high school1300 (54·6)
 Completed high school or higher degree1079 (45·4)
Marital status
 Married150 (6·3)
 Single (never married)2211 (92·8)
 Widowed/Divorced22 (0·9)
Number of children (N = 2368)
 No children448 (18·9)
 1 child795 (33·6)
  ≥ 2 children1125 (47·5)
 Employed1026 (43·0)
Income level (South African rand/month) (N = 2360)
  < 2000 rand (< USD $150)1785 (75·6)
  > 2000 rand (> USD $150)575 (24·4)
HIV and Medical History
 Previously tested HIV1705 (71·7)
 Previously tested HIV positive, among those tested (N = 1694)430 (25·4)
Partner HIV status (N = 2374)
 Unknown1315 (55·4)
 HIV-negative390 (16·4)
 HIV-positive669 (28·2)
 Ever tested Cryptococcus positive5 (0·2)
 Ever received Cryptococcus treatment, among those tested positive (N = 5)3 (60·0)
Clinical and Laboratory Testing
 CD4 count (cells/mm3): median (IQR)317 (173, 491)
  < 100 cells/mm3325 (13·6)
 100–199 cells/mm3354 (14·9)
 200+ cells/mm31656 (69·5)
 Not available48 (2·0)
Laboratory-based serum Cryptococcal Antigen EIA (N = 1308)
 Positive15 (1·1)
 Negative1294 (98·8)
  1. EIA—enzyme immunoassay; POC—point-of-care